Accelerate PEGylated therapeutics with a partner that has mastered conjugation chemistry, scale-up, and commercialization. This resource shows how FUJIFILM Biotechnologies optimizes PEGylation via DoE, de-risks heterogeneity with integrated analytics, and delivers robust control strategies across the product lifecycle—spanning E. coli–expressed proteins and both liquid and solid-phase chemistries up to 3000 L. Download now to see how our end-to-end expertise and future-ready approaches like site-specific PEGylation, continuous processing, and advanced chromatography can help you bring safer, longer-acting biologics to market faster. Fill out the form on this page to discover more.

Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy